These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27663383)

  • 21. Comparison of Submicron Particle Counting Methods with a Heat Stressed Monoclonal Antibody: Effect of Electrolytes and Implications on Sample Preparation.
    Stelzl A; Grabarek A; Schneid S; Jiskoot W; Menzen T; Winter G
    J Pharm Sci; 2022 Jul; 111(7):1992-1999. PubMed ID: 35081405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No Touching! Abrasion of Adsorbed Protein Is the Root Cause of Subvisible Particle Formation During Stirring.
    Sediq AS; van Duijvenvoorde RB; Jiskoot W; Nejadnik MR
    J Pharm Sci; 2016 Feb; 105(2):519-529. PubMed ID: 26869415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oil-Immersion Flow Imaging Microscopy for Quantification and Morphological Characterization of Submicron Particles in Biopharmaceuticals.
    Krause N; Kuhn S; Frotscher E; Nikels F; Hawe A; Garidel P; Menzen T
    AAPS J; 2021 Jan; 23(1):13. PubMed ID: 33398482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.
    Kalonia C; Kumru OS; Prajapati I; Mathaes R; Engert J; Zhou S; Middaugh CR; Volkin DB
    J Pharm Sci; 2015 Feb; 104(2):536-47. PubMed ID: 25302696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Submicron Protein Particle Characterization using Resistive Pulse Sensing and Conventional Light Scattering Based Approaches.
    Barnett GV; Perhacs JM; Das TK; Kar SR
    Pharm Res; 2018 Feb; 35(3):58. PubMed ID: 29423663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution.
    Nayak A; Colandene J; Bradford V; Perkins M
    J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Evaluation of Two Methods for Preparative Fractionation of Proteinaceous Subvisible Particles--Differential Centrifugation and FACS.
    Boll B; Folzer E; Finkler C; Huwyler J; Mahler HC; Schmidt R; Koulov AV
    Pharm Res; 2015 Dec; 32(12):3952-64. PubMed ID: 26195006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.
    Telikepalli SN; Kumru OS; Kalonia C; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2014 Mar; 103(3):796-809. PubMed ID: 24452866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The application of STEP-technology® for particle and protein dispersion detection studies in biopharmaceutical research.
    Gross-Rother J; Herrmann N; Blech M; Pinnapireddy SR; Garidel P; Bakowsky U
    Int J Pharm; 2018 May; 543(1-2):257-268. PubMed ID: 29604370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preanalytical, analytical, and biological variation of blood plasma submicron particle levels measured with nanoparticle tracking analysis and tunable resistive pulse sensing.
    Mørk M; Pedersen S; Botha J; Lund SM; Kristensen SR
    Scand J Clin Lab Invest; 2016 Sep; 76(5):349-60. PubMed ID: 27195974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Factors Affecting Nanoparticle Tracking Analysis Results With Synthetic and Protein Nanoparticles.
    Krueger AB; Carnell P; Carpenter JF
    J Pharm Sci; 2016 Apr; 105(4):1434-43. PubMed ID: 27019960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions.
    Wright M
    Methods Mol Biol; 2012; 906():511-24. PubMed ID: 22791460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Particles in therapeutic protein formulations, Part 1: overview of analytical methods.
    Zölls S; Tantipolphan R; Wiggenhorn M; Winter G; Jiskoot W; Friess W; Hawe A
    J Pharm Sci; 2012 Mar; 101(3):914-35. PubMed ID: 22161573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation.
    Wuchner K; Büchler J; Spycher R; Dalmonte P; Volkin DB
    J Pharm Sci; 2010 Aug; 99(8):3343-61. PubMed ID: 20229596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticle Tracking Analysis for Multiparameter Characterization and Counting of Nanoparticle Suspensions.
    Griffiths D; Carnell-Morris P; Wright M
    Methods Mol Biol; 2020; 2118():289-303. PubMed ID: 32152988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical Evaluation of Microfluidic Resistive Pulse Sensing for Quantification and Sizing of Nanometer- and Micrometer-Sized Particles in Biopharmaceutical Products.
    Grabarek AD; Weinbuch D; Jiskoot W; Hawe A
    J Pharm Sci; 2019 Jan; 108(1):563-573. PubMed ID: 30176253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Submicron Size Particles of a Murine Monoclonal Antibody Are More Immunogenic Than Soluble Oligomers or Micron Size Particles Upon Subcutaneous Administration in Mice.
    Kijanka G; Bee JS; Korman SA; Wu Y; Roskos LK; Schenerman MA; Slütter B; Jiskoot W
    J Pharm Sci; 2018 Nov; 107(11):2847-2859. PubMed ID: 30003898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-Dimensional Homodyne Light Detection (3D-HLD) for High-Throughput Submicron Particle Analysis in (Highly Concentrated) Protein Biopharmaceuticals, Viral Vectors, and LNPs.
    Brandstetter D; Helbig C; Osawa K; Minemura H; Anzai Y; Torisu T; Uchiyama S; Menzen T; Friess W; Hawe A
    J Pharm Sci; 2024 Apr; 113(4):891-899. PubMed ID: 37926233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow speed alters the apparent size and concentration of particles measured using NanoSight nanoparticle tracking analysis.
    Tong M; Brown OS; Stone PR; Cree LM; Chamley LW
    Placenta; 2016 Feb; 38():29-32. PubMed ID: 26907379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.